Severe preeclampsia cured by heparin in a patient with twin-twin transfusion syndrome

Heparin therapy for preeclampsia has been reported .frequently. Most of the authors used heparin toprevent thrombosis and achieved good results. But its mechanism is not clear. Here we describe a case of severe early-onset preeclampsia complicated with hypercoagulable state, fetal growth restriction...

Full description

Saved in:
Bibliographic Details
Published inChinese medical journal Vol. 120; no. 3; pp. 263 - 264
Main Authors Chu, Hong-nü, Zhou, Cai-yun
Format Journal Article
LanguageEnglish
Published China Department of Pathology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China%Department of Pathology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China 05.02.2007
Affiliated Hospital of the School of Medicine, Hangzhou Normal University, Hangzhou 310018, China
Subjects
Adult
Anticoagulants - therapeutic use
Female
Fetofetal Transfusion - drug therapy
Heparin - therapeutic use
Humans
Pre-Eclampsia - drug therapy
Pregnancy
先兆子痫
双胎输血综合症
heparin
placenta
heparinase
preeclampsia
Online AccessGet full text

Cover

More Information
Summary:Heparin therapy for preeclampsia has been reported .frequently. Most of the authors used heparin toprevent thrombosis and achieved good results. But its mechanism is not clear. Here we describe a case of severe early-onset preeclampsia complicated with hypercoagulable state, fetal growth restriction, and twin-twin transfusion syndrome, that responded well to heparin.
Bibliography:heparin
preeclampsia; heparin; heparinase; placenta
heparinase
11-2154/R
placenta
preeclampsia
R714.244
ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0366-6999
2542-5641
DOI:10.1097/00029330-200702010-00021